李媛;曾克武;王学美;
LI Yuan;ZENG Ke-wu;WANG Xue-mei;Research Laboratory of Integration of Traditional and Western Medicine,First Hospital of Peking University;State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University;

• 1:北京大学第一医院中西医结合研究室
• 2:北京大学药学院天然药物与仿生药物国家重点实验室

摘要(Abstract)：

糖尿病是一种慢性代谢障碍性疾病,随着发病率的逐年增高,已成为人类健康的主要威胁之一。脑微血管病变是糖尿病的特征性病理改变,是糖尿病脑部慢性并发症的病理基础,主要见于阿尔茨海默症和腔隙性脑梗死患者,是导致糖尿病患者致死致残的主要原因之一。其致病机制复杂,涉及多元醇代谢异常、糖化反应亢进、氧化应激、β淀粉样蛋白跨血脑屏障的异常转运、蛋白激酶C激活等多个方面,以发病机制为靶点的治疗可能会为预防和延缓糖尿病脑微血管病变的发生发展带来新的希望。目前,对糖尿病脑微血管病变的机制、诊断和治疗方法的研究较为广泛,已成为医学研究的一大热点。该文拟对糖尿病诱发的脑微血管病变的发病机制,临床诊断与治疗策略方面的研究进行综述,以期为糖尿病脑微血管病变的预防和治疗提供新的思路。
Diabetes mellitus,a kind of chronic metabolic disease,has become one of major threats to human health with an increasing incidence.As a basic pathology of chronic complications related to diabetes mellitus,cerebral microangiopathy is mainly found in patients with Alzheimer's disease and lacunar infarction,and becomes one of the main reasons of death and disability in diabetic patients.The pathogenesis of cerebral microangiopathy is complicated,involving such signal pathways as metabolic abnormalities of polyol,saccharification hyperactivity,oxidative stress,abnormal transport of amyloid-β across blood-brain barrier and protein kinase C activation.Treatment targeting at related pathogenesis may bring a new hope to prevention and delay of the occurrence and development of cerebral microangiopathy of diabetes mellitus.Currently,pathogenesis,diagnosis and therapies for cerebral microangiopathy of diabetes mellitus have become hot topics in medical studies.This article reviews pathogenesis,clinical diagnosis and treatment for cerebral microangiopathy of diabetes mellitus,in order to provide new ideas for the prevention and treatment of cerebral microangiopathy of diabetes mellitus.

关键词(KeyWords)： 糖尿病;脑微血管病变;发病机制;诊断;治疗方法
diabetes mellitus;cerebral microangiopathy;pathogenesis;diagnosis;therapy

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金重点项目(81530099)

作者(Authors): 李媛;曾克武;王学美;
LI Yuan;ZENG Ke-wu;WANG Xue-mei;Research Laboratory of Integration of Traditional and Western Medicine,First Hospital of Peking University;State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University;

DOI: 10.19540/j.cnki.cjcmm.2017.0104

参考文献(References)：

• [1]Zetter B R.The endothelial cells of large and small blood vessels[J].Diabetes,1981,30(Suppl2):24.
• [2]黄艳,吴兴临,张建中,等.糖尿病大鼠脑内微血管细胞外信号调节激酶磷酸化的研究[J].宁夏医科大学学报,2012,34(9):881.
• [3]李芸,柳弥,吴碧华,等.胰高血糖素样肽-1受体与紧密连接相关蛋白5在糖尿病大鼠脑微血管内皮的表达变化[J].中华脑科疾病与康复杂志:电子版,2014,4(3):21.
• [4]王悦.糖尿病脑病研究进展[J].中华现代内科学杂志,2008,5(5):415.
• [5]姚蔚,张倩,方琦,等.2型糖尿病血管并发症与早期认知障碍临床相关性研究[J].中国全科医学,2011,14(35):4045.
• [6]左玲俊,徐俊冕,季建林,等.并发微血管病变的2型糖尿病患者的认知功能研究[J].中国临床心理学杂志,2001,9(2):102.
• [7]周厚广,董强,胡仁明.糖尿病性脑血管病的研究进展[J].中国脑血管病杂志,2009,6(1):49.
• [8]Chandra D,Ramana K V,Friedrich B,et al.Role of aldose reductase in TNF-α-induced apoptosis of vascular endothelial cells[J].Chem Biol Interact,2003,143:605.
• [9]Hamada Y,Hammon K,Raskin P.Correlation between erythrocyte aldose reductase activity and the width of skeletal-muscle capillary basement membrane in insulin-dependent diabetes mellitus[J].J Diabetes Complicat,1992,6(4):242.
• [10]Hudson B I,Schmidt A M.RAGE:a novel target for drug intervention in diabetic vascular disease[J].Pharm Res-Dordr,2004,21(7):1079.
• [11]Skrha J.Pathogenesis of angiopathy in diabetes[J].Acta Diabetol,2003,40(2):s324.
• [12]常在,陆茵.糖尿病微血管病变及治疗药物的研究进展[J].南京中医药大学学报:自然科学版,2003,2(2):123.
• [13]Tuttle K,Anderberg R,Meek R.Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet[J].Am J Nephrol,2009,29(3):171.
• [14]杨红英,李树清,王卓,等.实验性糖尿病鼠脑微血管病变与氧化应激反应的研究[J].中国微循环,2009,13(4):250.
• [15]Oktem F,Ozguner F,Yilmaz H R,et al.Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase,albumin and renal oxidative markers in diabetic rats[J].Clin Exp Pharmacol P,2006,33(1/2):95.
• [16]Thallasbonke V,Thorpe S R,Coughlan M T,et al.Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway[J].Diabetes,2008,57(2):460.
• [17]Koya D,King G L.Protein kinase C activation and the development of diabetic complications[J].Diabetes,1998,47(6):859.
• [18]朱加明,刘志红.己糖胺通路与糖尿病及其并发症[J].肾脏病与透析肾移植杂志,2002,11(5):458.
• [19]James L R,Tang D,Ingram A,et al.Flux through the hexosamine pathway is a determinant of nuclear factorκB-dependent promoter activation[J].Diabetes,2002,51(4):1146.
• [20]胥文娟,朱梅佳,赵张宁,等.罗格列酮经LRP-1途径降低糖尿病大鼠脑微/小血管中β-淀粉样蛋白含量的研究[J].山东大学学报:医学版,2012,50(6):5.
• [21]Deane R,Wu Z,Zlokovic B V.RAGE(Yin)versus LRP(Yang)balance regulates Alzheimer amyloidβ-peptide clearance through transport across the blood-brain barrier[J].Stroke,2004,35(11 suppl 1):2628.
• [22]Hong H,Liu L P,Liao J M,et al.Downregulation of LRP1[correction of LPR1]at the blood-brain barrier in streptozotocininduced diabetic mice[J].Neuropharmacology,2009,56(6/7):1054.
• [23]王苗,朱梅佳,赵张宁.不同年龄糖尿病大鼠脑组织LRP-1表达与Aβ1-40的相关性[J].山东大学学报:医学版,2010,3(3):19.
• [24]Li P L,Hao H,Jian M L,et al.Upregulation of RAGE at the blood-brain barrier in streptozotocin-induced diabetic mice[J].Synapse,2009,63(8):636.
• [25]胡怀东,陈莉芬,胡长林.高糖对脑微血管内皮细胞活力和内皮素-1的影响[J].重庆医科大学学报,2007,31(6):801.
• [26]Yang J,Nan W,Yu Z,et al.Roles of SIRT1 in high glucose-induced endothelial impairment:association with diabetic atherosclerosis[J].Arch Med Res,2011,42(5):354.
• [27]李雪梅.e NOS与糖尿病脑微血管病变机制及干预研究[D].南充:川北医学院,2013.
• [28]Ghribi O,Larsen B,Schrag M,et al.High cholesterol content in neurons increases BACE,β-amyloid,and phosphorylated tau levels in rabbit hippocampus[J].Exp Neurol,2006,200(2):460.
• [29]王小林,张舜.糖尿病微血管病变分析[J].中国疗养医学,2011,20(11):1009.
• [30]Schmidt A M,Hori O,Brett J,et al.Cellular receptors for advanced glycation end products.Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions[J].Arterioscl Throm Vas,1994,14(10):1521.
• [31]郑世荣,刘凤英,田牛,等.糖尿病大鼠红细胞对脑组织损伤的影响[J].微循环学杂志,1999,3(3):5.
• [32]付享征,金玲,沈洁.急性脑梗死与糖尿病临床关系探讨[J].中国临床保健杂志,2005,8(4):359.
• [33]王乃东,阎胜利.糖尿病与脑梗死的关系研究进展[J].药品评价,2011,8(1):137.
• [34]贾安奎.2型糖尿病患者微血管病变与血小板活化关系的研究[J].中国误诊学杂志,2006,6(21):4105.
• [35]Biswas S,Zhao Y A,Gardner T,et al.PDGF-and insulin/IGF-1-specific distinct modes of class IA PI 3-kinase activation in normal rat retinas and RGC-5 retinal ganglion cells[J].Invest Ophth Vis Sci,2008,49(8):3687.
• [36]岳红,柳洁.高同型半胱氨酸血症与糖尿病及其微血管并发症的研究进展[J].中国基层医药,2006,13(5):869.
• [37]庄妍,林来祥.胰岛素样生长因子-1与糖尿病微血管并发症[J].国际内分泌代谢杂志,2009,29(2):123.
• [38]倪青.糖尿病脑血管病的中西医结合诊断与治疗[J].实用糖尿病杂志,2012(1):58.
• [39]沈洁,薛耀明,张云昆,等.经颅多普勒检测糖尿病大血管和微血管病变的应用价值[J].中华内科杂志,2002,41(3):172.
• [40]冯利得.糖化血红蛋白检测对糖尿病微血管病变评估的价值[J].中国现代药物应用,2012,18(2):54.
• [41]王志华,苏荣.同型半胱氨酸与糖尿病周围神经病变的关系的研究进展[J].实用糖尿病杂志,2013(3):9.
• [42]夏世念.血小板参数在2型糖尿病微血管病变中的变化及意义[J].内蒙古中医药,2012,31(11):94.
• [43]兰丽珍,弓军胜,谭芳,等.急性血糖波动加剧氧化应激引起糖尿病微血管并发症的研究[J].中西医结合心脑血管病杂志,2013,11(6):678.
• [44]Sacco R L,Adams R,Albers G,et al.Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack:a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke:co-sponsored by the Council on Cardiovascular Radiology and Intervention:the American Academy of Neurology affirms the value of this guideline[J].Circulation,2006,113(10):e409.
• [45]刘朋.中药降糖有效成分及其药理作用的研究[J].河北医药,2011,33(24):3790.
• [46]郭东杰,袁肖寒,蔡曼,等.降血脂西药与中药研究现状与展望[J].黑龙江医药,2014,27(1):31.
• [47]Felix C,Gillis M,Driedzic W R,et al.Effects of propionyl-Lcarnitine on isolated mitochondrial function in the reperfused diabetic rat heart[J].Diabetes Res Clin Pr,2001,53(1):17.
• [48]李红.糖尿病微血管病变发病机制和治疗靶点[J].浙江大学学报:医学版,2006,35(3):233.
• [49]Jain S K,Rains J,Jones K.Effect of curcumin on protein glycosylation,lipid peroxidation,and oxygen radical generation in human red blood cells exposed to high glucose levels[J].Free Radical Bio Med,2006,41(1):92.
• [50]赵瑛,陈峰.白藜芦醇对高糖下脑微血管内皮细胞NADPH氧化酶的影响及干预机制[J].成都:中华医学会第十三次全国神经病学学术会议,2010.
• [51]俞灵莺.桑叶总黄酮对糖尿病大鼠抗氧化作用[J].现代中西医结合杂志,2007,16(35):5245.
• [52]景怡,景荣琴,胡天惠,等.玉米须总黄酮对糖尿病高脂血症大鼠血脂、血糖水平的影响及抗氧化作用[J].中药药理与临床,2011,27(2):85.
• [53]叶真,倪海祥,黄琦,等.地骨皮提取液对糖尿病肥胖大鼠血清炎症因子及抗氧化功能的影响[J].中华临床医师杂志:电子版,2007,1(5):52.
• [54]杨哲.醛糖还原酶抑制剂和糖尿病并发症[J].国际药学研究杂志,1999(4):217.
• [55]Zeng K W,Li J,Dong X,et al.Anti-neuroinflammatory efficacy of the aldose reductase inhibitor FMHM via phospholipase C/protein kinase C-dependent NF-κB and MAPK pathways[J].Toxical Appl Pharm,2013,273(1):159.
• [56]李海岛,冯苏秀,叶儒,等.密蒙花正丁醇提取物对糖尿病大鼠血糖和醛糖还原酶的影响[J].中草药,2008,39(1):87.
• [57]王秀军,明义,孙丽萍,等.黄芩苷对糖尿病大鼠组织醛糖还原酶活性及肾脏细胞凋亡的影响[J].中国老年学杂志,2007,27(23):2278.
• [58]刘长山,王秀军,柳林,等.氨基胍、黄芩苷对糖尿病大鼠组织非酶糖化及视网膜细胞凋亡的影响[J].中国现代医药杂志,2009,11(6):33.
• [59]许惠琴,朱荃,李祥,等.7味中药对体外非酶糖化终产物生成的抑制作用[J].中草药,2002,32(2):145.
• [60]邹梦晨,薛耀明.蛋白激酶C抑制剂对高糖致血管内皮细胞高通透性的保护作用[J].南方医科大学学报,2012,32(12):1787.
• [61]叶立,李建宇,李月鹏,等.灯盏花素对大鼠脑微血管内皮细胞损伤的保护作用[J].中草药,2011,42(5):955.
• [62]王淑丽.大蒜素对糖尿病大血管病变的保护机制研究[D].济南:山东大学,2015.
• [63]Chen F,Dong R R,Zhong K L,et al.Antidiabetic drugs restore abnormal transport of amyloid-βacross the blood-brain barrier and memory impairment in db/db mice[J].Neuropharmacology,2015,101:123.
• [64]丛潇,王友政,张文生.晚期糖基化终末产物受体与阿尔茨海默病[J].中国老年学,2010,30(12):1759.
• [65]张忠,薛卫国,白丽敏,等.益智汤对APP695转基因小鼠行为学及脑组织LRP-1和RAGE表达的影响[J].中华中医药杂志,2012,27(10):2696.
• [66]曾永保,梅志刚,王明智,等.耳针对糖尿病大鼠脑微血管炎症损伤保护作用机制研究[J].时珍国医国药,2012,23(11):2886.
• [67]梅志刚,曾永保,王明智,等.电针耳甲区对糖尿病大鼠脑微血管内皮细胞肿瘤坏死因子-αmRNA、细胞黏附因子-1和血管间黏附分子-1蛋白表达的影响[J].针刺研究,2012,37(6):440.
• [68]Amarenco P,Bogousslavsky J,Rd C A,et al.High-dose atorvastatin after stroke or transient ischemic attack[J].N Engl J Med,2006,355(6):549.
• [69]Ronda Turner,R Holman,Irene M Stratton,et al.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:Ukpds 38[J].BMJ,1998,317:703.
• [70]时乐,黎蕾.糖尿病血管并发症线粒体氧化损伤机制及药物治疗进展[J].中华老年医学杂志,2006,25(3):228.
• [71]Forbes J T V,Mc T,Hw F,et al.The breakdown of pre-existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes[J].FASEB J,2003,17(10):1762.
• [72]Thallasbonke V,Lindschau C,Rizkalla B,et al.Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a p Protein kinase C-α-dependent pathway[J].Diabetes,2004,53(11):2921.
• [73]Degenhardt T P,Alderson N L,Arrington D D,et al.Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat[J].Kidney Int,2002,61(3):939.
• [74]陈勇,朱禧星,钟学礼.醛糖还原酶抑制剂与糖尿病慢性并发症[J].国际内科学杂志,1992(9):389.
• [75]Tuttle K R,Bakris G L,Toto R D,et al.The effect of ruboxistaurin on nephropathy in type 2 diabetes[J].Diabetes Care,2005,28(11):2686.
• [76]Tamaki C,Ohtsuki S,Terasaki T.Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide(1-40)by intracellular translocation of low-density lipoprotein receptor-related protein 1(LRP-1)to the plasma membrane in hepatocytes[J].Mol Pharmacol,2007,72(4):850.